Sep
3
2010
The best-known — or, conversely, most infamous — investment bank proprietary trading desk is apparently on its way to being wound down. Goldman Sachs is closing its Principal Strategies group, which trades using the firm’s own money, Bloomberg News reported Friday, citing unnamed sources. The reason? The much-discussed “Volcker Rule,” which aims to limit banks’ [...]
Sep
3
2010
Goldman Said to Plan Closing Prop Trading Desk
The best-known — or, conversely, most infamous — investment bank proprietary trading desk is apparently on its way to being wound down. Goldman Sachs is closing its Principal Strategies group, which trades using the firm’s own money, Bloomberg News reported Friday, citing unnamed sources. The reason? The much-discussed “Volcker Rule,” which aims to limit banks’ [...]
Sep
3
2010
Report: Pentagon Declined to Probe Hundreds of Child Porn Purchases
The Defense Department investigated only a small percentage out of hundreds of alleged cases of Pentagon employees using government computers to purchase child pornography, according to a Yahoo! News investigation published Friday. The cases came to light during a 2006 Immigration and Customs Enforcement probe, called Project Flicker, into the use of credit cards and [...]
Sep
3
2010
Report: Pentagon Declined to Probe Hundreds of Child Porn Purchases
The Defense Department investigated only a small percentage out of hundreds of alleged cases of Pentagon employees using government computers to purchase child pornography, according to a Yahoo! News investigation published Friday. The cases came to light during a 2006 Immigration and Customs Enforcement probe, called Project Flicker, into the use of credit cards and [...]
Sep
3
2010
Abbott Halts Sale of Flu Vaccine Business
Abbott Laboratories has called a halt to the sale of its European flu-vaccine unit because of a dissapointing run of initial bids, The Wall Street Journal reported. Abbott announced it would be selling the business in June and recieved interest from four or five bidders, but offers did not top €500 million ($640 million), which [...]
Sep
3
2010
Abbott Halts Sale of Flu Vaccine Business
Abbott Laboratories has called a halt to the sale of its European flu-vaccine unit because of a dissapointing run of initial bids, The Wall Street Journal reported. Abbott announced it would be selling the business in June and recieved interest from four or five bidders, but offers did not top €500 million ($640 million), which [...]

Twitter
Facebook